Agios Pharmaceuticals | Stammkapital



Ordinary Share Capital Veränderung Datum
AbbVie USD 18M 0 2024-12
Agios Pharmaceuticals USD 74K 1000 2025-03
Alnylam Pharmaceuticals USD 1.3M 10K 2025-03
Amgen USD 33.58B 45M 2025-03
Arrowhead Research USD 230K 12K 2025-03
Astellas Pharma JPY 1.79B 101.21B 2025-06
AstraZeneca USD 1.55B 1.16B 2025-06
Bayer EUR 2.52B 0 2025-03
Biogen USD 100K 0 2025-03
BioMarin Pharmaceutical USD 192K 1000 2025-03
Bristol-Myers Squibb USD 292M 0 2025-03
Daiichi Sankyo JPY 1.85B 48.15B 2025-06
Eli Lilly USD 592.6M 200K 2025-03
Exelixis USD 270.13M 269.86M 2025-07
Gilead Sciences USD 1000K 0 2024-12
GlaxoSmithKline GBP 1.35B 1000K 2025-03
Incyte USD 194.12M 193.93M 2025-06
Ionis Pharmaceuticals USD 159K 1000 2025-03
Merck USD 1.79B 0 2025-03
Moderna USD 38.7K 100 2025-03
Novartis USD 793M 0 2024-12
Novartis USD 793M 0 2024-12
Pfizer USD 481M 1000K 2025-03
Regeneron Pharmaceuticals USD 0 102K 2025-03
Roche Holding CHF 107M 0 2024-06
Sarepta Therapeutics USD 10K 0 2025-03
Vertex Pharmaceuticals USD 2.6M 0 2024-12


Agios Pharmaceuticals Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.